{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:21:18Z","timestamp":1791825678199,"version":"4.3.4"},"reference-count":63,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M752253"],"award-info":[{"award-number":["2024M752253"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403838"],"award-info":[{"award-number":["82403838"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2025ZNSFSC1711"],"award-info":[{"award-number":["2025ZNSFSC1711"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2023NSFSC1666"],"award-info":[{"award-number":["2023NSFSC1666"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.apsb.2025.09.030","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T05:24:36Z","timestamp":1758605076000},"page":"6638-6656","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Injectable hydrogel-mediated co-delivery of oncolytic adenovirus and melphalan for retinoblastoma control and vision preservation"],"prefix":"10.1016","volume":"15","author":[{"given":"Guoqing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongdong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshuang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Licong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5107-8604","authenticated-orcid":false,"given":"Yiliu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongsong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2025.09.030_bib1","article-title":"Retinoblastoma","volume":"1","author":"Dimaras","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.apsb.2025.09.030_bib2","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.ophtha.2014.03.028","article-title":"Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study","volume":"121","author":"Francis","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.apsb.2025.09.030_bib3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/jamaophthalmol.2013.7666","article-title":"Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results","volume":"132","author":"Shields","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.apsb.2025.09.030_bib4","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/bjophthalmol-2011-301450","article-title":"Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications","volume":"96","author":"Munier","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.apsb.2025.09.030_bib5","first-page":"305","article-title":"Toxicity to intravitreal melphalan in a patient with retinoblastoma","volume":"67","author":"Solaz-Ruiz","year":"2023","journal-title":"Rom J Ophthalmol"},{"key":"10.1016\/j.apsb.2025.09.030_bib6","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrd4663","article-title":"Oncolytic viruses: a new class of immunotherapy drugs","volume":"14","author":"Kaufman","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2025.09.030_bib7","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41577-018-0014-6","article-title":"Integrating oncolytic viruses in combination cancer immunotherapy","volume":"18","author":"Bommareddy","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2025.09.030_bib8","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41573-019-0029-0","article-title":"Optimizing oncolytic virotherapy in cancer treatment","volume":"18","author":"Harrington","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2025.09.030_bib9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41571-022-00719-w","article-title":"Therapy with oncolytic viruses: progress and challenges","volume":"20","author":"Shalhout","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.apsb.2025.09.030_bib10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/jnci\/djj003","article-title":"Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication","volume":"98","author":"Aghi","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.apsb.2025.09.030_bib11","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1158\/0008-5472.CAN-12-3056","article-title":"Macrophage delivery of an oncolytic virus abolishes tumor regrowth and metastasis after chemotherapy or irradiation","volume":"73","author":"Muthana","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2025.09.030_bib12","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1158\/1078-0432.CCR-10-0196","article-title":"Phase I\/II study of oncolytic HSV GM-CSF in combination with radiotherapy and cisplatin in untreated stage III\/IV squamous cell cancer of the head and neck","volume":"16","author":"Harrington","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2025.09.030_bib13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.exer.2009.03.007","article-title":"Oncolytic adenovirus delivering herpes simplex virus thymidine kinase suicide gene reduces the growth of human retinoblastoma in an in vivo mouse model","volume":"89","author":"Ji","year":"2009","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.apsb.2025.09.030_bib14","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1167\/iovs.09-3516","article-title":"Inhibition of retinoblastoma in vitro and in vivo with conditionally replicating oncolytic adenovirus H101","volume":"51","author":"Song","year":"2010","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.apsb.2025.09.030_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/02713680490504894","article-title":"Evaluation of the antitumor effects of Herpes simplex virus lacking ribonucleotide reductase in a murine retinoblastoma model","volume":"29","author":"Cullinan","year":"2004","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.apsb.2025.09.030_bib16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11060-005-9036-6","article-title":"Destruction of human retinoblastoma after treatment by the E variant of encephalomyocarditis virus","volume":"77","author":"Adachi","year":"2006","journal-title":"J Neuro Oncol"},{"key":"10.1016\/j.apsb.2025.09.030_bib17","doi-asserted-by":"crossref","first-page":"10653","DOI":"10.1158\/0008-5472.CAN-07-2352","article-title":"Treatment of invasive retinoblastoma in a murine model using an oncolytic picornavirus","volume":"67","author":"Wadhwa","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2025.09.030_bib18","doi-asserted-by":"crossref","first-page":"438","DOI":"10.18632\/oncotarget.1686","article-title":"RB1 gene inactivation by chromothripsis in human retinoblastoma","volume":"5","author":"McEvoy","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.apsb.2025.09.030_bib19","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1126\/science.3983638","article-title":"Genetic origin of mutations predisposing to retinoblastoma","volume":"228","author":"Cavenee","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.apsb.2025.09.030_bib20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/(SICI)1098-1004(199910)14:4<283::AID-HUMU2>3.0.CO;2-J","article-title":"RB1 gene mutations in retinoblastoma","volume":"14","author":"Lohmann","year":"1999","journal-title":"Hum Mutat"},{"key":"10.1016\/j.apsb.2025.09.030_bib21","first-page":"1490","article-title":"An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy","volume":"63","author":"Jakubczak","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2025.09.030_bib22","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3389\/fonc.2019.01182","article-title":"Oncolytic adenovirus-a nova for gene-targeted oncolytic viral therapy in HCC","volume":"9","author":"Abudoureyimu","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.apsb.2025.09.030_bib23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cbi.2016.04.011","article-title":"Targeting HSP90\/Survivin using a cell permeable structure based peptido-mimetic shepherdin in retinoblastoma","volume":"252","author":"Venkatesan","year":"2016","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.apsb.2025.09.030_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153011","article-title":"Targeting Survivin enhances chemosensitivity in retinoblastoma cells and orthotopic tumors","volume":"11","author":"Ferrario","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2025.09.030_bib25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4161\/cbt.13.2.18436","article-title":"Combination of oncolytic adenovirus and dacarbazine attenuates antitumor ability against uveal melanoma cells via cell cycle block","volume":"13","author":"Cun","year":"2012","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.apsb.2025.09.030_bib26","doi-asserted-by":"crossref","first-page":"10736","DOI":"10.3390\/ijms130910736","article-title":"Combined treatment with an oncolytic adenovirus and antitumor activity of vincristine against retinoblastoma cells","volume":"13","author":"Song","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2025.09.030_bib27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejps.2019.03.021","article-title":"Novel facile thermosensitive hydrogel as sustained and controllable gene release vehicle for breast cancer treatment","volume":"134","author":"Zhao","year":"2019","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.apsb.2025.09.030_bib28","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jconrel.2023.04.028","article-title":"Sustained release hydrogel for durable locoregional chemoimmunotherapy for BRAF-mutated melanoma","volume":"357","author":"Kim","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.09.030_bib29","article-title":"Stimuli-responsive silk fibroin for on-demand drug delivery","volume":"2","author":"Lin","year":"2023","journal-title":"Smart Med"},{"key":"10.1016\/j.apsb.2025.09.030_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/SMMD.20230023","article-title":"Developing conductive hydrogels for biomedical applications","volume":"3","author":"Wang","year":"2024","journal-title":"Smart Med"},{"key":"10.1016\/j.apsb.2025.09.030_bib31","article-title":"Antibacterial hydrogels for bacteria-infected wound treatment","volume":"9","author":"Li","year":"2025","journal-title":"Bio Technol"},{"key":"10.1016\/j.apsb.2025.09.030_bib32","doi-asserted-by":"crossref","first-page":"22152","DOI":"10.1021\/acsami.9b05520","article-title":"Cell-laden electroconductive hydrogel simulating nerve matrix to deliver electrical cues and promote neurogenesis","volume":"11","author":"Wu","year":"2019","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.apsb.2025.09.030_bib33","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ymthe.2022.08.021","article-title":"CXCL11-armed oncolytic adenoviruses enhance CAR-T cell therapeutic efficacy and reprogram tumor microenvironment in glioblastoma","volume":"31","author":"Wang","year":"2023","journal-title":"Mol Ther"},{"key":"10.1016\/j.apsb.2025.09.030_bib34","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1038\/s41417-024-00839-8","article-title":"Systemic delivery of tannic acid-ferric-masked oncolytic adenovirus reprograms tumor microenvironment for improved therapeutic efficacy in glioblastoma","volume":"31","author":"Wang","year":"2024","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.apsb.2025.09.030_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/viro.2000.0468","article-title":"Cell receptors involved in adenovirus entry","volume":"274","author":"Nemerow","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.apsb.2025.09.030_bib36","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1038\/bjc.2013.509","article-title":"Presence of the coxsackievirus and adenovirus receptor (CAR) in human neoplasms: a multitumour array analysis","volume":"109","author":"Reeh","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.apsb.2025.09.030_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122260","article-title":"Targeting survivin for cancer therapy: strategies, small molecule inhibitors and vaccine based therapeutics in development","volume":"335","author":"Kondapuram","year":"2023","journal-title":"Life Sci"},{"key":"10.1016\/j.apsb.2025.09.030_bib38","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1002\/1873-3468.13848","article-title":"The adenovirus death protein\u2015a small membrane protein controls cell lysis and disease","volume":"594","author":"Georgi","year":"2020","journal-title":"FEBS Lett"},{"key":"10.1016\/j.apsb.2025.09.030_bib39","first-page":"444.e1","article-title":"Clinical significance of high levels of survivin and transforming growth factor beta-1 proteins in aqueous humor and serum of retinoblastoma patients","volume":"20","author":"Shehata","year":"2016","journal-title":"J AAPOS Off Publ Am Assoc Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.apsb.2025.09.030_bib40","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s40425-018-0458-z","article-title":"Oncolytic virus immunotherapy: future prospects for oncology","volume":"6","author":"Raja","year":"2018","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.apsb.2025.09.030_bib41","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.2147\/OPTH.S417370","article-title":"Ocular survival following intravitreal melphalan as adjuvant treatment for vitreous retinoblastoma seeding","volume":"17","author":"Alahmadi","year":"2023","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.apsb.2025.09.030_bib42","series-title":"Assessing ocular toxicology in laboratory animals","first-page":"1","author":"V\u00e9zina","year":"2013"},{"key":"10.1016\/j.apsb.2025.09.030_bib43","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0092-8674(00)80439-0","article-title":"Crx, a novel otx-like homeobox gene, shows photoreceptor-specific expression and regulates photoreceptor differentiation","volume":"91","author":"Furukawa","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2025.09.030_bib44","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1471-4159.2009.06322.x","article-title":"Differential CRX and OTX2 expression in human retina and retinoblastoma","volume":"111","author":"Glubrecht","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.apsb.2025.09.030_bib45","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.canlet.2016.06.012","article-title":"Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination","volume":"380","author":"Pascual-Pasto","year":"2016","journal-title":"Cancer Lett"},{"key":"10.1016\/j.apsb.2025.09.030_bib46","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/jamaophthalmol.2015.0900","article-title":"Association of cone-rod homeobox transcription factor messenger RNA with pediatric metastatic retinoblastoma","volume":"133","author":"Torbidoni","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.apsb.2025.09.030_bib47","doi-asserted-by":"crossref","first-page":"5894","DOI":"10.1021\/acs.nanolett.4c01267","article-title":"Sustained secretion of CCL21 via an implantable cell reservoir hydrogel enhances the systemic antitumor effect of radiotherapy","volume":"24","author":"Gao","year":"2024","journal-title":"Nano Lett"},{"key":"10.1016\/j.apsb.2025.09.030_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2021.214352","article-title":"Cyclodextrin-based host\u2013guest supramolecular hydrogels for local drug delivery","volume":"454","author":"Fang","year":"2022","journal-title":"Coord Chem Rev"},{"key":"10.1016\/j.apsb.2025.09.030_bib49","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jconrel.2022.06.028","article-title":"Hydrogel-forming microarray patches with cyclodextrin drug reservoirs for long-acting delivery of poorly soluble cabotegravir sodium for HIV pre-exposure prophylaxis","volume":"348","author":"Volpe-Zanutto","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.09.030_bib50","doi-asserted-by":"crossref","first-page":"52346","DOI":"10.1021\/acsami.1c14679","article-title":"Antioxidative and conductive nanoparticles-embedded cell niche for neural differentiation and spinal cord injury repair","volume":"13","author":"Wu","year":"2021","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.apsb.2025.09.030_bib51","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12951-023-01992-2","article-title":"Nanotechnology-based ocular drug delivery systems: recent advances and future prospects","volume":"21","author":"Li","year":"2023","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.apsb.2025.09.030_bib52","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41392-023-01407-6","article-title":"Oncolytic virotherapy: basic principles, recent advances and future directions","volume":"8","author":"Lin","year":"2023","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.apsb.2025.09.030_bib53","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cytogfr.2020.07.007","article-title":"Tumour vasculature: friend or foe of oncolytic viruses?.","volume":"56","author":"Santry","year":"2020","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.apsb.2025.09.030_bib54","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.biomaterials.2017.09.009","article-title":"A hydrogel matrix prolongs persistence and promotes specific localization of an oncolytic adenovirus in a tumor by restricting nonspecific shedding and an antiviral immune response","volume":"147","author":"Jung","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2025.09.030_bib55","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ajo.2024.12.012","article-title":"The role of intravitreal chemotherapy as an adjunctive treatment for retinoblastoma: a systematic review and single-arm meta-analysis","volume":"273","author":"Bravo-Gonzalez","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.apsb.2025.09.030_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121493","article-title":"Topical instillation of cell-penetrating peptide-conjugated melphalan blocks metastases of retinoblastoma","volume":"284","author":"Jiang","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2025.09.030_bib57","doi-asserted-by":"crossref","first-page":"915","DOI":"10.7150\/thno.103266","article-title":"Advances in adhesive hydrogels applied for ophthalmology: an overview focused on the treatment","volume":"15","author":"Yan","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2025.09.030_bib58","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.actbio.2020.08.013","article-title":"Steroid-eluting contact lenses for corneal and intraocular inflammation","volume":"116","author":"Bengani","year":"2020","journal-title":"Acta Biomater"},{"key":"10.1016\/j.apsb.2025.09.030_bib59","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000345","article-title":"Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma","volume":"8","author":"Saha","year":"2020","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.apsb.2025.09.030_bib60","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.21037\/jgo-21-792","article-title":"Effects of recombinant human adenovirus type 5 combined with transarterial chemoembolization on postoperative metastasis and recurrence of hepatocellular carcinoma patients","volume":"12","author":"Wu","year":"2021","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.apsb.2025.09.030_bib61","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41420-023-01626-4","article-title":"Recombinant oncolytic adenovirus armed with CCL5, IL-12, and IFN-\u03b3 promotes CAR-T infiltration and proliferation in vivo to eradicate local and distal tumors","volume":"9","author":"Fang","year":"2023","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.apsb.2025.09.030_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0286323","article-title":"Novel conditionally replicating adenovirus-mediated efficient detection of circulating tumor cells in lung cancer patients","volume":"18","author":"Ikemoto","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2025.09.030_bib63","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.it.2017.11.006","article-title":"Antitumor benefits of antiviral immunity: an underappreciated aspect of oncolytic virotherapies","volume":"39","author":"Gujar","year":"2018","journal-title":"Trends Immunol"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525006343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525006343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:37:35Z","timestamp":1777624655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383525006343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":63,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2211383525006343"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2025.09.030","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Injectable hydrogel-mediated co-delivery of oncolytic adenovirus and melphalan for retinoblastoma control and vision preservation","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2025.09.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}